Tags |
|
|
Links |
|
|
Digg It - E-mail Marketing - The Marketing Tool that Never Fails
E-mailing is one of he most obvious reasons why a lot of people are trying
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
to engage in the use of the Internet. As e-mail grew very popular as a med
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
ium of communication, it has become also the considered most useful marketi
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
g tool. Aside from the fact that it is cheaper, this tool is capable of rea
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
ching the prospective clients on a far reached avenue. But with the abuse
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
f e-mailing, spam filters gave gradually become a lot stricter. The e-mail
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
marketing as a tool of advertisement is now faced with this problem. To ma
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
ke sure that your e-mail marketing material goes right thru your client’s m
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
ilbox and eventually be read, please take note of the following guidelines.
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
• Eliminate those who do not want to receive your e-mail marketing materi
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
l immediately and pursue diligently on sending these materials to those who
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
willingly want. With this action, you are assured of not being tagged as
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
a spammer by those who do not wish to receive any communication from you.
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
s for those who wish to receive form you, diligently invest on them.
• Che
• Che
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
ck your mailing list fro any duplicate e-mail addresses. By doing this, yo
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
are eliminating the possibility of being accused to doing e-mail spoofing
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
and scamming.
• Create segmentation on your e-mail. By properly categoriz
• Create segmentation on your e-mail. By properly categoriz
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
ing the types of people or e-mail addresses who directly or indirectly show
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
d interest on your product, you would easily determine which ones are to be
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
given focus and high priority and which ones are to be given least priorit
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.diggit.org.ua/article/61849/diggit-Email-Marketing---The-Marketing-Tool-that-Never-Fails.html">E-mail Marketing - The Marketing Tool that Never Fails</a>
BB link (for phorums):
[url=http://www.diggit.org.ua/article/61849/diggit-Email-Marketing---The-Marketing-Tool-that-Never-Fails.html]E-mail Marketing - The Marketing Tool that Never Fails[/url]
Related Articles:
Join the Work-At-Home Employment Revolution
Bookmark it:
|